ATE527273T1 - Verfahren zur herstellung von optisch aktivem dihydropyridinphosphonsäureester - Google Patents

Verfahren zur herstellung von optisch aktivem dihydropyridinphosphonsäureester

Info

Publication number
ATE527273T1
ATE527273T1 AT04771582T AT04771582T ATE527273T1 AT E527273 T1 ATE527273 T1 AT E527273T1 AT 04771582 T AT04771582 T AT 04771582T AT 04771582 T AT04771582 T AT 04771582T AT E527273 T1 ATE527273 T1 AT E527273T1
Authority
AT
Austria
Prior art keywords
optically active
active substance
crystal
compound
formula
Prior art date
Application number
AT04771582T
Other languages
English (en)
Inventor
Yasutaka Takada
Hiroo Matsumoto
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE527273T1 publication Critical patent/ATE527273T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04771582T 2003-10-01 2004-08-12 Verfahren zur herstellung von optisch aktivem dihydropyridinphosphonsäureester ATE527273T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003342761 2003-10-01
PCT/JP2004/011607 WO2005033117A1 (ja) 2003-10-01 2004-08-12 光学活性なジヒドロピリジンホスホン酸エステルの製造方法

Publications (1)

Publication Number Publication Date
ATE527273T1 true ATE527273T1 (de) 2011-10-15

Family

ID=34419273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04771582T ATE527273T1 (de) 2003-10-01 2004-08-12 Verfahren zur herstellung von optisch aktivem dihydropyridinphosphonsäureester

Country Status (7)

Country Link
US (1) US20060276437A1 (de)
EP (1) EP1676852B1 (de)
JP (1) JP4530172B2 (de)
KR (1) KR101031577B1 (de)
AT (1) ATE527273T1 (de)
TW (1) TWI361801B (de)
WO (1) WO2005033117A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0699458B2 (ja) 1986-01-23 1994-12-07 日産化学工業株式会社 ジヒドロピリジン−5−ホスホン酸環状エステル類
JPH0211592A (ja) * 1988-06-29 1990-01-16 Nissan Chem Ind Ltd 光学活性なジヒドロピリジンホスホン酸エステル
JP2850376B2 (ja) * 1988-08-02 1999-01-27 日産化学工業株式会社 抗癌剤薬効増強剤

Also Published As

Publication number Publication date
TWI361801B (en) 2012-04-11
EP1676852A4 (de) 2008-11-12
TW200513453A (en) 2005-04-16
KR20060080928A (ko) 2006-07-11
JP4530172B2 (ja) 2010-08-25
US20060276437A1 (en) 2006-12-07
JPWO2005033117A1 (ja) 2007-10-04
KR101031577B1 (ko) 2011-04-27
EP1676852B1 (de) 2011-10-05
EP1676852A1 (de) 2006-07-05
WO2005033117A1 (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
RU2001102263A (ru) Медицинские нитратные соли
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
PE20050480A1 (es) Acido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0] non-1(7)-en-2-il)alquil]fosfonico y derivados
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
RU2003131687A (ru) Камзилат амлодипина, способ его получения и фармацевтическая композиция на его основе
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
PT79669A (de) Verfahren zur racematspaltung bicyclischer imino-alpha-carbonsaeureester
DE60310559D1 (de) Prozess zur herstellung von dioxanessigsäureestern
ES2201166T3 (es) Procedimiento de racemizacion para su utilizacion en la fabricacion de levobupivacaina y agentes anestesicos correspondientes a base de piperidincarboxanilida.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE527273T1 (de) Verfahren zur herstellung von optisch aktivem dihydropyridinphosphonsäureester
DE60312214D1 (de) Verfahren zur herstellung von(4e)-5-chloro-2-isopropyl-4-pentensäureester und optischaktivem isomer davon
RU97118134A (ru) Новые противовирусные гомокарбоциклические нуклеозидные производные замещенных пиримидиндионов, способы их получения и композиции, содержащие их в качестве активных ингредиентов
EP1773740B1 (de) Neurologisch aktive verbindungen
DE602005026577D1 (de) Verfahren zur Herstellung optisch aktiver (S)- oder (R)-beta -Aminosäuren und optisch aktiver (R)- oder (S)-beta -Aminosäureester, und optisch aktive (S)- oder (R)-2-Alkoxyethylester von beta-Aminosäuren.
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
KR910009687A (ko) Nmda-저해 제약성분
ATE491686T1 (de) Amlodipin-gentisat und verfahren zu dessen herstellung
ATE399757T1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
DE502004006253D1 (de) Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
KR880011096A (ko) 광학 활성 옥소-이소인돌리닐 유도체
ES2074430T3 (es) Compuesto opticamente activo, procedimiento para su fabricacion y composicion de cristal liquido que lo contiene.
PE20060014A1 (es) Taxanos con sustituyentes lactiloxilo en el c7

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties